Literature DB >> 12054541

A secreted form of human ADAM9 has an alpha-secretase activity for APP.

Nika Hotoda1, Hisashi Koike, Noboru Sasagawa, Shoichi Ishiura.   

Abstract

ADAM9 (MDC9, meltrin gamma) is a member of the ADAM family of metalloproteases, which play important roles in cell-cell fusion, intracellular signaling, and other cellular functions. Here we cloned a novel form of human ADAM9, designated hADAM9s (s for short), which lacks the carboxyl-terminus. Human ADAM9s was found to be secreted from transfected COS cells. RT-PCR analysis demonstrated that the mRNA for hADAM9s is expressed in human brain, liver, heart, kidney, lung, and trachea. When hADAM9s was co-expressed in COS cells with APP and treated with phorbol ester, the APP was digested exclusively at the alpha-secretory site. These results suggest that hADAM9s has an alpha-secretase-like activity for APP. Non-amyloidgenic cleavage of APP may occur at the plasma membrane. Our new results support a new therapeutic strategy to decrease in the Abeta content by directly activating ADAM9 in the extracellular space. Copyright 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054541     DOI: 10.1016/S0006-291X(02)00302-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase.

Authors:  Thomas Tousseyn; Amantha Thathiah; Ellen Jorissen; Tim Raemaekers; Uwe Konietzko; Karina Reiss; Elke Maes; An Snellinx; Lutgarde Serneels; Omar Nyabi; Wim Annaert; Paul Saftig; Dieter Hartmann; Bart De Strooper
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

2.  Sorting nexin 9 (SNX9) regulates levels of the transmembrane ADAM9 at the cell surface.

Authors:  Kasper J Mygind; Theresa Störiko; Marie L Freiberg; Jacob Samsøe-Petersen; Jeanette Schwarz; Olav M Andersen; Marie Kveiborg
Journal:  J Biol Chem       Date:  2018-04-05       Impact factor: 5.157

3.  Domain integration of ADAM family proteins: Emerging themes from structural studies.

Authors:  Tom Cm Seegar; Stephen C Blacklow
Journal:  Exp Biol Med (Maywood)       Date:  2019-07-23

Review 4.  The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.

Authors:  Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2015-01-07       Impact factor: 5.590

5.  Identification of novel substrates for the serine protease HTRA1 in the human RPE secretome.

Authors:  Eunkyung An; Supti Sen; Sung Kyu Park; Heather Gordish-Dressman; Yetrib Hathout
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-05       Impact factor: 4.799

Review 6.  The Distinct Role of ADAM17 in APP Proteolysis and Microglial Activation Related to Alzheimer's Disease.

Authors:  Meng Qian; Xiaoqiang Shen; Huanhuan Wang
Journal:  Cell Mol Neurobiol       Date:  2015-06-29       Impact factor: 5.046

7.  Zinc metalloproteinases and amyloid Beta-Peptide metabolism: the positive side of proteolysis in Alzheimer's disease.

Authors:  Mallory Gough; Catherine Parr-Sturgess; Edward Parkin
Journal:  Biochem Res Int       Date:  2010-09-30

Review 8.  ADAM function in embryogenesis.

Authors:  Dominique Alfandari; Catherine McCusker; Hélène Cousin
Journal:  Semin Cell Dev Biol       Date:  2008-09-30       Impact factor: 7.727

9.  Potential contribution of exosomes to the prion-like propagation of lesions in Alzheimer's disease.

Authors:  Valérie Vingtdeux; Nicolas Sergeant; Luc Buée
Journal:  Front Physiol       Date:  2012-07-05       Impact factor: 4.566

10.  Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals.

Authors:  Mahdi Ghani; Christiane Reitz; Rong Cheng; Badri Narayan Vardarajan; Gyungah Jun; Christine Sato; Adam Naj; Ruchita Rajbhandary; Li-San Wang; Otto Valladares; Chiao-Feng Lin; Eric B Larson; Neill R Graff-Radford; Denis Evans; Philip L De Jager; Paul K Crane; Joseph D Buxbaum; Jill R Murrell; Towfique Raj; Nilufer Ertekin-Taner; Mark Logue; Clinton T Baldwin; Robert C Green; Lisa L Barnes; Laura B Cantwell; M Daniele Fallin; Rodney C P Go; Patrick A Griffith; Thomas O Obisesan; Jennifer J Manly; Kathryn L Lunetta; M Ilyas Kamboh; Oscar L Lopez; David A Bennett; Hugh Hendrie; Kathleen S Hall; Alison M Goate; Goldie S Byrd; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Lindsay A Farrer; Margaret A Pericak-Vance; Joseph H Lee; Gerard D Schellenberg; Peter St George-Hyslop; Richard Mayeux; Ekaterina Rogaeva
Journal:  JAMA Neurol       Date:  2015-11       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.